A metrological approach for the assessment of selenium status in human serum

This work addresses a metrological approach for the assessment of Se status in humans in terms of serum selenomethionine (SeMet). The quantification of SeMet was carried out using a primary method of chemical analysis, namely species-specific isotope dilution (SSID) in combination with HPLC coupled to collision/reaction cell inductively coupled plasma-mass spectrometry. SeMet was released from the serum selenoalbumin (a seleno-containing protein where SeMet is randomly incorporated) by enzymatic hydrolysis of the whole serum. This study is a follow-up of the analytical method development reported previously, and it focuses primarily on the evaluation of the uncertainty budget and the main uncertainty sources for SeMet determination in three commercial serums, namely BCR-637 (certified for total Se) and two serum standards, SERONORM level 1 (SERO-L1) and 2 (SERO-L2) (with indicative concentrations of total Se). The metrological approach reported here could be considered as a pilot study in terms of metrological determination of SeMet in human serum, hence being suitable for method validation and inter-laboratory comparison.